Predicting the Pathologic Complete Response After Neoadjuvant Pembrolizumab in Muscle-Invasive Bladder Cancer

BACKGROUND: In the PURE-01 study (NCT02736266), we aimed to evaluate the ability to predict the pathologic complete response (pT0N0) after pembrolizumab by using clinical and tumor biomarkers. METHODS: In an open-label, single-arm, phase 2 study, 3 courses of 200 mg pembrolizumab preceding radical c...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Natl Cancer Inst
Main Authors: Bandini, Marco, Ross, Jeffrey S, Raggi, Daniele, Gallina, Andrea, Colecchia, Maurizio, Lucianò, Roberta, Giannatempo, Patrizia, Farè, Elena, Pederzoli, Filippo, Bianchi, Marco, Colombo, Renzo, Gandaglia, Giorgio, Fossati, Nicola, Marandino, Laura, Capitanio, Umberto, Deho’, Federico, Ali, Siraj M, Madison, Russell, Chung, Jon H, Salonia, Andrea, Briganti, Alberto, Montorsi, Francesco, Necchi, Andrea
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7781448/
https://ncbi.nlm.nih.gov/pubmed/32516377
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djaa076
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados